Ameriprise’s Vascular Solutions Inc VASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-211,947
Closed -$11.9M 3809
2016
Q4
$11.9M Sell
211,947
-22,821
-10% -$1.16M 0.01% 1394
2016
Q3
$11.3M Sell
234,768
-84,780
-27% -$3.95M 0.01% 1350
2016
Q2
$13.3M Buy
319,548
+29,606
+10% +$1.1M 0.01% 1185
2016
Q1
$9.43M Sell
289,942
-6,819
-2% -$197K 0.01% 1459
2015
Q4
$10.2M Buy
296,761
+59,666
+25% +$2.02M 0.01% 1426
2015
Q3
$7.68M Buy
237,095
+41,151
+21% +$1.47M ﹤0.01% 1670
2015
Q2
$6.8M Buy
195,944
+39,703
+25% +$1.29M ﹤0.01% 1917
2015
Q1
$4.74M Buy
156,241
+111,214
+247% +$3.19M ﹤0.01% 2138
2014
Q4
$1.22M Buy
45,027
+44,407
+7,162% +$1.21M ﹤0.01% 2781
2014
Q3
$15K Buy
620
+180
+41% +$4.27K ﹤0.01% 4637
2014
Q2
$10K Hold
440
﹤0.01% 4687
2014
Q1
$12K Hold
440
﹤0.01% 4468
2013
Q4
$10K Sell
440
-1,029
-70% -$20.2K ﹤0.01% 4390
2013
Q3
$24K Hold
1,469
﹤0.01% 4300
2013
Q2
$21K Buy
+1,469
New +$23.1K ﹤0.01% 4263

Other funds holding VASC

Ameriprise's VASC Position: Q1 2017 in Review

Ameriprise sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 211,947 shares — an estimated $11.9M sold.

Ameriprise first reported a position in VASC in Q2 2013 and held it in 15 quarters. The position peaked at $13.3M in Q2 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • Ameriprise reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • Ameriprise sold 211,947 Vascular Solutions Inc shares in Q1 2017, an estimated $11.9M.
  • Ameriprise first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 15 quarters.
  • Ameriprise's Vascular Solutions Inc position peaked at $13.3M in Q2 2016.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Ameriprise's 13F filing for Q1 2017, filed 5 May 2017.